Chen X, Liu X, Zhang C, Xia H, Qin X, Guo Y, et al
In a briefing document released prior to the panel discussion, the FDAs internal reviewers said that Ocaliva had failed to demonstrate efficacy in one of its confirmatory trials
Dungan and DeSantis., Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus
BPC-157 falls into the category of research chemicals available for in vitro and animal laboratory use, a legal classification that prohibits sale with claims of human health benefits or as a finished dosage product for human consumption
The ThinWell Clinic Services We create customized, physician-supervised weight loss plans in Columbus, GA that look at the individual for the most effective treatments
Circ Res 1997